Agency Forms Undergoing Paperwork Reduction Act Review, 13824-13825 [2023-04492]
Download as PDF
<![CDATA[
13824
Federal Register / Vol. 88, No. 43 / Monday, March 6, 2023 / Notices
Dated: February 27, 2023.
Kimberly D. Bose,
Secretary.
[FR Doc. 2023–04452 Filed 3–3–23; 8:45 am]
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
BILLING CODE 6717–01–P
[FR Doc. 2023–04512 Filed 3–3–23; 8:45 am]
BILLING CODE P
FEDERAL RESERVE SYSTEM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
lotter on DSK11XQN23PROD with NOTICES1
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
Centers for Disease Control and
Prevention
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington DC 20551–0001, not later
than March 21, 2023.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Lisa Elsenbast, Minneapolis,
Minnesota, individually and as cotrustee with Annette Sarazine-Jensen,
Omaha, Nebraska, Monica Anderegg,
Edina, Minnesota, and Julia T. Sarazine,
Chicago, Illinois, of the Charles L.
Sarazine 2022 Trust Agreement,
Minneapolis, Minnesota; and Maryanna
Sarazine, Algona, Iowa; to become
members of the Spies-Sarazine Family
Control Group, a group acting in concert
to retain voting shares of Emmetsburg
Bank Shares, Inc., and thereby
indirectly retain voting shares of Iowa
Trust & Savings Bank, both of
Emmetsburg, Iowa.
VerDate Sep<11>2014
19:26 Mar 03, 2023
Jkt 259001
[30Day–23–22IV]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘The Muscular
Dystrophy Surveillance, Tracking, and
Research Network (MD STARnet) Living
with Muscular Dystrophy
Questionnaire’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on
September 23, 2022 to obtain comments
from the public and affected agencies.
CDC did not receive comments related
to the previous notice. This notice
serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
The Muscular Dystrophy
Surveillance, Tracking, and Research
Network (MD STARnet) Living with
Muscular Dystrophy Questionnaire—
New—National Center on Birth Defects
and Developmental Disabilities
(NCBDDD), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Since its establishment in 2002, the
MD STARnet has been a populationbased surveillance system that aims to
identify and collect clinical data on
individuals with muscular dystrophy
(MD) in select surveillance areas. MD
STARnet identifies and collects data on
individuals with MD at sources
including healthcare facilities where
patients with MD receive care and
administrative datasets such as vital
records and hospital discharge data.
Although MDs are rare genetic diseases
with an estimated prevalence of 16.1/
100,000, they have a high impact on
affected individuals, their families, and
society. MDs can be classified into nine
major groups: Duchenne MD (DMD),
Becker MD (BMD), myotonic dystrophy
(DM), facioscapulohumeral muscular
dystrophy (FSHD), limb-girdle MD
(LGMD), Congenital MD (CMD), EmeryDreifuss MD (EDMD), Oculopharyngeal
MD (OPMD), and distal MD. A recent
MD STARnet study has estimated the
combined prevalence for DMD and BMD
to be 1.92–2.48/10,000 males age 5–9
years old. MD STARnet aims to improve
understanding of MDs and ultimately
the quality of life of individuals and
their families living with MD.
Individuals with MD frequently report
pain and fatigue, but studies have
primarily been conducted in single
clinics and limited to the three most
common MDs (DMD, DM, and FSHD).
E:\FR\FM\06MRN1.SGM
06MRN1
13825
Federal Register / Vol. 88, No. 43 / Monday, March 6, 2023 / Notices
Population-based studies are needed to
describe the frequency and management
of pain and fatigue and their impact on
the lives of individuals with various
types of MD. The purpose of the
proposed study is to describe the
epidemiology of COVID–19 and flu and
the experience with pain, fatigue,
pregnancy, and infertility for adults
living with MD who are identified
through MD STARnet. Information will
be collected at the seven MD STARnet
surveillance sites and will occur
primarily via a survey of adult men and
women with muscular dystrophy. The
survey will primarily be web-based, but
a paper version and phone interview
will be provided to accommodate
participant preferences. The estimated
burden per response for the MD
STARnet Men Living with Muscular
Dystrophy Survey is 15 minutes. The
MD STARnet Women Living with
Muscular Dystrophy Survey includes
additional questions about pregnancy
and infertility, and the estimated burden
per response is 20 minutes.
Results generated from the study will
provide a better understanding of: (1)
the occurrence, testing, treatment and
severity of COVID–19 in relation to MD;
(2) vaccination status and reasons for
not receiving COVID–19 and flu
vaccinations; (3) the frequency,
intensity, and management of pain and
fatigue; and (4) the effect of having MD
on pregnancy and fertility on adults
living with MD. Ultimately, this
information can be used to develop
interventions that improve the lives of
people with MD and their families.
CDC requests OMB approval for two
years. The total estimated annualized
burden is 292 hours. Participation is
voluntary and there are no costs to
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Adult Males 18 and over .................................
MD STARnet Men Living with Muscular Dystrophy Survey.
MD STARnet Women Living with Muscular
Dystrophy Survey.
Adult Females 18 and over ............................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–04492 Filed 3–3–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-23–1204; Docket No. CDC–2023–
0013]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies to take this opportunity to
comment on a continuing information
collection, as required by the Paperwork
Reduction Act of 1995. This notice
invites comment on a proposed data
collection titled Behavioral Risk Factor
Surveillance System (BRFSS) Asthma
Call-back Survey (ACBS). The ACBS is
an in-depth asthma survey conducted
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
VerDate Sep<11>2014
19:26 Mar 03, 2023
Jkt 259001
on a subset of BRFSS respondents with
an asthma diagnosis with the goal to
strengthen the existing body of asthma
data and to address critical questions
surrounding the health and experiences
of persons with asthma.
DATES: Written comments must be
received on or before May 5, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2023–
0013 by any of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road, NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
538
1
15/60
472
1
20/60
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
SUPPLEMENTARY INFORMATION:
E:\FR\FM\06MRN1.SGM
06MRN1
]]>Agencies
[Federal Register Volume 88, Number 43 (Monday, March 6, 2023)]
[Notices]
[Pages 13824-13825]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04492]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-22IV]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``The Muscular Dystrophy Surveillance,
Tracking, and Research Network (MD STARnet) Living with Muscular
Dystrophy Questionnaire'' to the Office of Management and Budget (OMB)
for review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
September 23, 2022 to obtain comments from the public and affected
agencies. CDC did not receive comments related to the previous notice.
This notice serves to allow an additional 30 days for public and
affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
The Muscular Dystrophy Surveillance, Tracking, and Research Network
(MD STARnet) Living with Muscular Dystrophy Questionnaire--New--
National Center on Birth Defects and Developmental Disabilities
(NCBDDD), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Since its establishment in 2002, the MD STARnet has been a
population-based surveillance system that aims to identify and collect
clinical data on individuals with muscular dystrophy (MD) in select
surveillance areas. MD STARnet identifies and collects data on
individuals with MD at sources including healthcare facilities where
patients with MD receive care and administrative datasets such as vital
records and hospital discharge data. Although MDs are rare genetic
diseases with an estimated prevalence of 16.1/100,000, they have a high
impact on affected individuals, their families, and society. MDs can be
classified into nine major groups: Duchenne MD (DMD), Becker MD (BMD),
myotonic dystrophy (DM), facioscapulohumeral muscular dystrophy (FSHD),
limb-girdle MD (LGMD), Congenital MD (CMD), Emery-Dreifuss MD (EDMD),
Oculopharyngeal MD (OPMD), and distal MD. A recent MD STARnet study has
estimated the combined prevalence for DMD and BMD to be 1.92-2.48/
10,000 males age 5-9 years old. MD STARnet aims to improve
understanding of MDs and ultimately the quality of life of individuals
and their families living with MD.
Individuals with MD frequently report pain and fatigue, but studies
have primarily been conducted in single clinics and limited to the
three most common MDs (DMD, DM, and FSHD).
[[Page 13825]]
Population-based studies are needed to describe the frequency and
management of pain and fatigue and their impact on the lives of
individuals with various types of MD. The purpose of the proposed study
is to describe the epidemiology of COVID-19 and flu and the experience
with pain, fatigue, pregnancy, and infertility for adults living with
MD who are identified through MD STARnet. Information will be collected
at the seven MD STARnet surveillance sites and will occur primarily via
a survey of adult men and women with muscular dystrophy. The survey
will primarily be web-based, but a paper version and phone interview
will be provided to accommodate participant preferences. The estimated
burden per response for the MD STARnet Men Living with Muscular
Dystrophy Survey is 15 minutes. The MD STARnet Women Living with
Muscular Dystrophy Survey includes additional questions about pregnancy
and infertility, and the estimated burden per response is 20 minutes.
Results generated from the study will provide a better
understanding of: (1) the occurrence, testing, treatment and severity
of COVID-19 in relation to MD; (2) vaccination status and reasons for
not receiving COVID-19 and flu vaccinations; (3) the frequency,
intensity, and management of pain and fatigue; and (4) the effect of
having MD on pregnancy and fertility on adults living with MD.
Ultimately, this information can be used to develop interventions that
improve the lives of people with MD and their families.
CDC requests OMB approval for two years. The total estimated
annualized burden is 292 hours. Participation is voluntary and there
are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Adult Males 18 and over............ MD STARnet Men Living with 538 1 15/60
Muscular Dystrophy Survey.
Adult Females 18 and over.......... MD STARnet Women Living 472 1 20/60
with Muscular Dystrophy
Survey.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-04492 Filed 3-3-23; 8:45 am]
BILLING CODE 4163-18-P
